GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 129 filers reported holding GW PHARMACEUTICALS PLC in Q2 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $3,451,000 | -17.6% | 30,000 | 0.0% | 0.59% | -64.8% |
| Q2 2018 | $4,186,000 | +643.5% | 30,000 | +500.0% | 1.68% | +403.9% |
| Q1 2018 | $563,000 | -84.4% | 5,000 | -84.5% | 0.33% | -74.8% |
| Q4 2016 | $3,604,000 | -2.5% | 32,250 | +15.8% | 1.32% | +17.6% |
| Q3 2016 | $3,697,000 | +124.3% | 27,855 | +54.8% | 1.12% | +60.2% |
| Q2 2016 | $1,648,000 | – | 18,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |